{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:21:52Z","timestamp":1771356112614,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic lupus erythematosus is an autoimmune disease that can have cutaneous and systemic manifestations. Lupus panniculitis, also known as lupus mastitis, is a subset of chronic cutaneous lupus erythematosus that involves inflammation of the subcutaneous fat. The pathogenesis of lupus mastitis is not fully understood. Diagnosis involves a combination of skin manifestations, imaging, and pathologic confirmation. Treatment typically includes steroids and antimalarials, with more severe disease requiring additional immunosuppressive medications. This report highlights a case of lupus mastitis treated with rituximab and a possible relationship between this disease process and thrombotic disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 48-year-old African American female with systemic lupus erythematosus and antiphospholipid syndrome presented with new breast lesion. Mammography revealed calcifications and increased density with coarse trabecular pattern. Breast biopsy showed features of cutaneous lupus and occlusive vasculopathy. The patient was diagnosed with lupus mastitis and treated with anticoagulation, rituximab, mycophenolate mofetil, and quinacrine with resolution of her symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This patient experienced improvement in her breast symptoms with combination therapy including rituximab. There are only two other cases reported in literature of patients with lupus mastitis responding to rituximab, highlighting the possible role of B cell depleting therapy for those who have contraindications to standard treatments for lupus mastitis. While the pathophysiology of lupus mastitis is thought to be immune driven, some literature suggests that associated thrombosis commonly seen may be due to a physiologic overlap similar to antiphospholipid syndrome. The possible relationship between antiphospholipid syndrome and lupus mastitis and the use of antiplatelet and anticoagulation therapy is discussed and may warrant further investigation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04054-1","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:01:50Z","timestamp":1691539310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lupus mastitis and antiphospholipid syndrome treated with anticoagulation and immunosuppression: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-8825","authenticated-orcid":false,"given":"Lauren J.","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laarni C.","family":"Quimson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwakemi","family":"Onajin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly C.","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"4054_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ejrad.2017.04.023","volume":"92","author":"B Voizard","year":"2017","unstructured":"Voizard B, Lalonde L, Sanchez LM, et al. Lupus mastitis as a first manifestation of systemic disease: about two cases with a review of the literature. Eur J Radiol. 2017;92:124\u201331.","journal-title":"Eur J Radiol"},{"issue":"4","key":"4054_CR2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/jcm9040958","volume":"9","author":"R Goulabchand","year":"2020","unstructured":"Goulabchand R, Hafidi A, Van De Perre P, et al. Mastitis in autoimmune diseases: review of the literature, diagnostic pathway, and pathophysiological key players. J Clin Med. 2020;9(4):958.","journal-title":"J Clin Med"},{"issue":"2","key":"4054_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.anndiagpath.2012.09.003","volume":"17","author":"M Rosa","year":"2013","unstructured":"Rosa M, Mohammadi A. Lupus mastitis: a review. Ann Diagn Pathol. 2013;17(2):230\u20133.","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"4054_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.det.2008.06.002","volume":"26","author":"K Fraga","year":"2008","unstructured":"Fraga K, Garcia-Diez A. Lupus erythematosus panniculitis. Dermatol Clin. 2008;26(4):453\u201363.","journal-title":"Dermatol Clin"},{"key":"4054_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/archderm.139.1.50","volume":"139","author":"H Ts","year":"2003","unstructured":"Ts H, Lj J, Ma M, et al. Low dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus. Arch Dermatol Res. 2003;139:50\u20134.","journal-title":"Arch Dermatol Res"},{"key":"4054_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10067-009-1158-3","volume":"28","author":"A Mcardle","year":"2009","unstructured":"Mcardle A, Baker JF. A case of refractory lupus erythematosus profundus responsive to rituximab [case report]. Clin Rheumatol. 2009;28:745\u20136.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"4054_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1440-0960.2009.00539.x","volume":"50","author":"V Kieu","year":"2009","unstructured":"Kieu V, O\u2019Brien T, Yap LM, et al. Refractory subacute cutaneous lupus erythematous successfully treated with rituximab. Aust J Dermatol. 2009;50(3):202\u20136.","journal-title":"Aust J Dermatol."},{"issue":"12","key":"4054_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5070\/D30W81Q5ZS","volume":"18","author":"R Hunt","year":"2012","unstructured":"Hunt R, Robinson M, Patel R, Franks A. Antiphospholipid-antibody-associated panniculitis. Dermatol Online J. 2012;18(12):18.","journal-title":"Dermatol Online J"},{"key":"4054_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2340\/00015555-1528","volume":"93","author":"S Arai","year":"2013","unstructured":"Arai S, Katsuoka K, Eto H. An unusual form of lupus erythematosus profoundus associated with antiphospholipid syndrome: report of two cases. Acta Derm Venereol. 2013;93:581\u20132.","journal-title":"Acta Derm Venereol"},{"key":"4054_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/rheumatology\/38.8.796","volume":"38","author":"J Jimenez-Mazuecos","year":"1999","unstructured":"Jimenez-Mazuecos J, Yebra-Bango M, Sanchez-Ruiz A, Villarreal-Garcia-Lomas M. Weber-Christian disease associated with lupus anticoagulant and anticardiolipin antibodies. Rheumatology (Oxford). 1999;38:796.","journal-title":"Rheumatology (Oxford)"},{"key":"4054_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archderm.1992.01680160133022","volume":"128","author":"L Renfro","year":"1992","unstructured":"Renfro L, Franks AG, Grodberg M, et al. Painful nodules in a young female. Arch Dermatol. 1992;128:847.","journal-title":"Arch Dermatol"},{"issue":"4","key":"4054_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1525-1470.1999.00060.x","volume":"16","author":"HC Nousari","year":"1999","unstructured":"Nousari HC, Kimyai-Asadi A, Santana H, et al. Generalized lupus panniculitis and antiphospholipid syndrome in a patient without complement deficiency. Pediatr Dermatol. 1999;16(4):273\u20136.","journal-title":"Pediatr Dermatol."},{"issue":"3","key":"4054_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/archderm.1978.01640150046014","volume":"114","author":"RB Harris","year":"1978","unstructured":"Harris RB, Winkelmann RK. Lupus mastitis. Arch Dermatol. 1978;114(3):401\u20132.","journal-title":"Arch Dermatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04054-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T08:11:08Z","timestamp":1700295068000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04054-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4054"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04054-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"12 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Chicago IRB waived ethics approval for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors have competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}